InVivo Therapeutics Hldgs Corp (fka NVIVQ)

[Pemmanuel]

Great opportunity to buy NVIV. Whenever this stock got to this all time low range it bounced back with a fury. Previously when it got here it was because of very negative circumstances like former CEO leaving or having zero patients. This low is the only time ever where there are significant positives and a really good chance to exceed the target, obtain FDA approval, and go commercial in a year. NVIV has all the makings of a ten-bagger from now to say 16 months out. By end of this year it could be a 5X gain.